Integrating Quality into production to drive cost-effective innovation

13

As the emphasis of new drug development gravitates away from chemical synthesis towards new, ground-breaking therapies and vaccines, the requirements of manufacturing sites, equipment and processes need to be appropriate for this new environment. For young biotechs, scaling up production brings green-field challenges, while for more established pharma a shift may be required to ensure that facilities are optimised for new ways of working.